Back to Atlas
BSemi-durableStandard research/education caution
CMP-0225
Investigational
O-304 / O304 / ATX-304
Exercise mimetic / Metabolic
May improve glucose homeostasis, insulin resistance, microvascular perfusion, cardiac function and exercise capacity
Reading this compound Reference only
Information below is educational. Dosing, mechanisms and status fields are compiled from the source list at the bottom of this page — always verify against a licensed clinician before use.
Reference-only summary of publicly discussed or source-listed patterns. Not medical advice and not a personal recommendation.
Mechanism & Use
- Compound type
- Small molecule
- Primary mechanism
- Pan-AMPK activation by suppressing pAMPK dephosphorylation; mitochondrial effects
- Primary market use
- T2D / metabolic aging / exercise mimetic
Pharmacology
- Molecular weight (Da)
- 380.25
- Oral bioavailability
- Orally bioavailable; % not publicly established
- Half-life
- Not publicly established
- Route tags
- SubQ; Injectable; route-dependent
- Evidence level
- Human/Clinical
- Clinical status
- Investigational
- Value-for-money score
- 8 / 10
Reported protocol signal
No popular protocol verified yet; keep as reference compound until protocol signal is added.
For orientation only. See disclaimer — always consult a licensed clinician before use.
Notes
One of the stronger metabolic additions due oral route and human translational data